Available on demand. In this informational webinar, Dr. Dmitry Kuksin, Nexcelom Senior Scientist, examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
Webinar on Demand: Role of Aneuploidy and DNA Damage in the Onset of Human Solid Tumors – Lessons from Mouse Models of Chromosome Losses
Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Please join our webinar, during which we will highlight the differences between trypan blue and fluorescence-based cell counting methods.
Stop by and learn more about our new Cellaca™ MX and how it revolutionizes how scientists count and characterize cells
Nexcelom Bioscience, a leading provider of cell counting and characterization products for the life science industry, announced the launch of the revolutionary high throughput, high-speed automated cell counter – Cellaca™ MX.
Video: PBMC Mediated Cytotoxicity Using Celigo Image Cytometry. Avoid hazardous radiation in chromium release assays by using image cytometry.
Video: Cellaca MX high-speed high throughput cell counter. As quick as 48 seconds for 24 samples. For cell lines and primary cells. Automation-ready.